{
     "PMID": "25332063",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20150708",
     "LR": "20170220",
     "IS": "1471-2202 (Electronic) 1471-2202 (Linking)",
     "VI": "15",
     "DP": "2014 Oct 21",
     "TI": "Time-dependent activation of MAPK/Erk1/2 and Akt/GSK3 cascades: modulation by agomelatine.",
     "PG": "119",
     "LID": "10.1186/s12868-014-0119-1 [doi]",
     "AB": "BACKGROUND: The novel antidepressant agomelatine, a melatonergic MT1/MT2 agonist combined with 5-HT2c serotonin antagonist properties, showed antidepressant action in preclinical and clinical studies. There is a general agreement that the therapeutic action of antidepressants needs the activation of slow-onset adaptations in downstream signalling pathways finally regulating neuroplasticity. In the last several years, particular attention was given to cAMP-responsive element binding protein (CREB)-related pathways, since it was shown that chronic antidepressants increase CREB phosphorylation and transcriptional activity, through the activation of calcium/calmodulin-dependent (CaM) and mitogen activated protein kinase cascades (MAPK/Erk1/2). Aim of this work was to analyse possible effects of chronic agomelatine on time-dependent changes of different intracellular signalling pathways in hippocampus and prefrontal/frontal cortex of male rats. To this end, measurements were performed 1 h or 16 h after the last agomelatine or vehicle injection. RESULTS: We have found that in naive rats chronic agomelatine, contrary to traditional antidepressants, did not increase CREB phosphorylation, but modulates the time-dependent regulation of MAPK/Erk1/2 and Akt/glycogen synthase kinase-3 (GSK-3) pathways. CONCLUSION: Our results suggest that the intracellular molecular mechanisms modulated by chronic agomelatine may be partly different from those of traditional antidepressants and involve the time-dependent regulation of MAPK/Erk1/2 and Akt/GSK-3 signalling pathways. This could exert a role in the antidepressant efficacy of the drug.",
     "FAU": [
          "Musazzi, Laura",
          "Seguini, Mara",
          "Mallei, Alessandra",
          "Treccani, Giulia",
          "Pelizzari, Mariagrazia",
          "Tornese, Paolo",
          "Racagni, Giorgio",
          "Tardito, Daniela"
     ],
     "AU": [
          "Musazzi L",
          "Seguini M",
          "Mallei A",
          "Treccani G",
          "Pelizzari M",
          "Tornese P",
          "Racagni G",
          "Tardito D"
     ],
     "AD": "Laboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases (CEND), Universita degli Studi di Milano, Via Balzaretti 9, Milano, 20133, Italy. laura.musazzi@unimi.it. Laboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases (CEND), Universita degli Studi di Milano, Via Balzaretti 9, Milano, 20133, Italy. mara.seguini@guest.unimi.it. Laboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases (CEND), Universita degli Studi di Milano, Via Balzaretti 9, Milano, 20133, Italy. alessandra.mallei@unimi.it. Laboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases (CEND), Universita degli Studi di Milano, Via Balzaretti 9, Milano, 20133, Italy. giulia.treccani@guest.unimi.it. Laboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases (CEND), Universita degli Studi di Milano, Via Balzaretti 9, Milano, 20133, Italy. mariagrazia.pelizzari@gmail.com. Laboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases (CEND), Universita degli Studi di Milano, Via Balzaretti 9, Milano, 20133, Italy. paolo.tornese@unimi.it. Laboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases (CEND), Universita degli Studi di Milano, Via Balzaretti 9, Milano, 20133, Italy. giorgio.racagni@unimi.it. Istituto di Ricovero e Cura a Carattere Scientifico Centro S. Giovanni di Dio-Fatebenefratelli, Brescia, Italy. giorgio.racagni@unimi.it. Laboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmacologiche e Biomolecolari and Center of Excellence on Neurodegenerative Diseases (CEND), Universita degli Studi di Milano, Via Balzaretti 9, Milano, 20133, Italy. daniela.tardito@unimi.it.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20141021",
     "PL": "England",
     "TA": "BMC Neurosci",
     "JT": "BMC neuroscience",
     "JID": "100966986",
     "RN": [
          "0 (Acetamides)",
          "0 (Antidepressive Agents)",
          "0 (Cyclic AMP Response Element-Binding Protein)",
          "138112-76-2 (S 20098)",
          "EC 2.7.11.1 (Proto-Oncogene Proteins c-akt)",
          "EC 2.7.11.26 (Glycogen Synthase Kinase 3)"
     ],
     "SB": "IM",
     "MH": [
          "Acetamides/*pharmacology",
          "Animals",
          "Antidepressive Agents/*pharmacology",
          "Blotting, Western",
          "Cyclic AMP Response Element-Binding Protein/metabolism",
          "Frontal Lobe/*drug effects/enzymology",
          "Glycogen Synthase Kinase 3/*metabolism",
          "Hippocampus/*drug effects/enzymology",
          "MAP Kinase Signaling System/*drug effects",
          "Male",
          "Phosphorylation/drug effects",
          "Proto-Oncogene Proteins c-akt/metabolism",
          "Random Allocation",
          "Rats, Sprague-Dawley",
          "Time Factors"
     ],
     "PMC": "PMC4207903",
     "EDAT": "2014/10/22 06:00",
     "MHDA": "2015/07/15 06:00",
     "CRDT": [
          "2014/10/22 06:00"
     ],
     "PHST": [
          "2014/08/08 00:00 [received]",
          "2014/10/09 00:00 [accepted]",
          "2014/10/22 06:00 [entrez]",
          "2014/10/22 06:00 [pubmed]",
          "2015/07/15 06:00 [medline]"
     ],
     "AID": [
          "10.1186/s12868-014-0119-1 [doi]",
          "s12868-014-0119-1 [pii]"
     ],
     "PST": "epublish",
     "SO": "BMC Neurosci. 2014 Oct 21;15:119. doi: 10.1186/s12868-014-0119-1.",
     "term": "hippocampus"
}